Sanofi SNY
NASDAQ SNY
$48.39 +0.02 (+0.04%)
At close: Nov 16, 2026 · 4:00 PM EST

Sanofi (SNY) Net Income towards Common Stockholders (2009 - 2026)

Updated

Sanofi's Net Income towards Common Stockholders was $8.1 billion in Q3 2026, up 97.5% from $4.1 billion a year earlier.

Analysis

Sanofi (SNY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sanofi's Net Income towards Common Stockholders was $9.46 billion through Sep 30, 2026, down 14.5% year-over-year; for FY2025, it came in at $8.83 billion, up 46.7% from FY2024.

  • Net Income towards Common Stockholders shows a five-year compound annual growth rate of -8.9% (FY2020 to FY2025).
  • In earlier years, Net Income towards Common Stockholders was $6.02 billion in FY2024 (+3.0%), $5.84 billion in FY2023 (-33.8%), $8.82 billion in FY2022 (+19.8%) and $7.36 billion in FY2021 (-47.5%).
  • The Q3 2026 figure marks the highest quarterly Net Income towards Common Stockholders since Q4 2022.
  • Compared with a year earlier, Net Income towards Common Stockholders was higher in four of the last six quarters, with growth averaging 61.2%.
  • The best year-over-year quarter for Net Income towards Common Stockholders over five years was Q4 2022 (growth of 683.6%); the worst was Q2 2026 (a decline of 91.1%).
  • Per Business Quant data, SNY's Net Income towards Common Stockholders in the three quarters before Q3 2026 was $398.69 million (Q2 2026), $1.89 billion (Q1 2026) and -$932.4 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.12 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.24 Bn
10 Sanofi 59.05 Bn 29.25 Bn 33.35 Bn 8.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8.10 Bn
Jun 30, 2026 398.69 Mn
Mar 31, 2026 1.89 Bn
Dec 31, 2025 -932.40 Mn
Sep 30, 2025 4.10 Bn
Jun 30, 2025 4.46 Bn
Mar 31, 2025 1.97 Bn
Dec 31, 2024 533.23 Mn
Sep 30, 2024 3.09 Bn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 -597.15 Mn
Sep 30, 2023 2.75 Bn
Jun 30, 2023 1.56 Bn
Mar 31, 2023 2.14 Bn
Dec 31, 2022 3.17 Bn
Sep 30, 2022 2.09 Bn
Jun 30, 2022 1.25 Bn
Mar 31, 2022 2.25 Bn
Dec 31, 2021 1.29 Bn
API Access

Sanofi Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=SNY&period=max&api_key=YOUR_API_KEY